Search Within

David Hyman

  1. "2017"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (23)
Groups
  1. Department of Medicine (53)
  2. Early Drug Development Service (53)
  3. Solid Tumor Oncology Division (53)
  4. GSK Faculty (36)
  5. Department of Pathology and Laboratory Medicine (34)
  6. Human Oncology and Pathogenesis Program (29)

More Groups

People
  1. Michael Berger (21)
  2. David Solit (19)
  3. Ahmet Zehir (18)
  4. Jose Baselga (16)
  5. Marc Ladanyi (15)
  6. Maria Arcila (15)

More People

Years
  1. 2017 (53)
Publications
  1. Journal of Clinical Oncology (13)
  2. Cancer Discovery (5)
  3. Clinical Cancer Research (4)
  4. Blood (3)
  5. Cancer Research (3)
  6. JCO Precision Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (16)
  2. American Association for Cancer Research (12)
  3. American Society of Hematology (3)
  4. Nature Publishing Group (3)
  5. Oxford University Press (3)
  6. American Medical Association (2)

More Publishers

Results (53)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma
    Journal Article

    Shukla, N.; Roberts, S. S.; Baki, M. O.; Mushtaq, Q.; Goss, P. E.; Park, B. H.; Gundem, G.; Tian, K.; Geiger, H.; Redfield, K.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Journal Article

    Abida, W.; Armenia, J.; Gopalan, A.; Brennan, R.; Walsh, M.; Barron, D.; Danila, D.; Rathkopf, D.; Morris, M.; Slovin, S.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • OncoKB: A precision oncology knowledge base
    Journal Article

    Chakravarty, D.; Gao, J.; Phillips, S.; Kundra, R.; Zhang, H.; Wang, J.; Rudolph, J. E.; Yaeger, R.; Soumerai, T.; Nissan, M. H.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Efficacy of vemurafenib in patients (pts) with non-small cell lung cancer (NSCLC) with BRAF(V600) mutation
    Meeting Abstract

    Subbiah, V.; Gervais, R.; Riely, G. J.; Hollebecque, A.; Blay, J. Y.; Felip, E.; Schuler, M. H.; Goncalves, A.; Italiano, A.; Keedy, V. L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A prospective analysis of germline alterations (GA) in biliary tract cancer (BTC)
    Meeting Abstract

    Lowery, M. A.; Jordan, E.; Kemel, Y.; Mukherjee, S.; Cercek, A.; Kemeny, N. E.; Varghese, A. M.; Rusek, M.; Boucher, T. M.; Mandelker, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • First-in-class oral ERK1/2 inhibitor Ulixertinib (BVD-523) in patients with advanced solid tumors: Final results of a phase I dose escalation and expansion study
    Meeting Abstract

    Li, B. T.; Janku, F.; Patel, M. R.; Sullivan, R. J.; Flaherty, K.; Buchbinder, E. I.; Lacouture, M. E.; Varghese, A. M.; Wong, D. J. L.; Sznol, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Integrating clinical pharmacy services into patient care in an early-phase clinical trial clinic
    Meeting Abstract

    Liu, D.; Dang, T. O.; Harnicar, S.; Kargus, K.; Evans, L. A.; So-Kwan, Y. Y.; Hyman, D. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Vemurafenib in patients with BRAF(V600) mutant glioma: A cohort of the histology-independent VE-basket study
    Meeting Abstract

    Hyman, D. M.; Kaley, T. J.; Hollebecque, A.; Subbiah, V.; Ahnert, J. R.; Lockhart, A. C.; Keedy, V. L.; Hofheinz, R.; Lobbedez, F. J.; Blay, J. Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The efficacy of larotrectinib (LOXO-101), a selective tropomyosin receptor kinase (TRK) inhibitor, in adult and pediatric TRK fusion cancers
    Meeting Abstract

    Hyman, D. M.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Farago, A. F.; Pappo, A. S.; Demetri, G. D.; El-Deiry, W. S.; Lassen, U. N.; Dowlati, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save